TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis phase II trial tests a combination of low-dose bevacizumab and atezolizumab (immunotherapy) along with targeted chemotherapy delivered directly to the liver via a catheter. The goal is to improve tumor shrinkage in 38 patients with advanced liver cancer that cannot be surgic…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New combo therapy targets unresectable liver cancer
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced liver cancer that cannot be surgically removed. The treatment includes a procedure that delivers chemotherapy directly to the tumor (TACE) plus two drugs that boost the immune system and block blood vessel grow…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC